{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:04:01Z","timestamp":1760267041616},"reference-count":30,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,1,25]],"date-time":"2006-01-25T00:00:00Z","timestamp":1138147200000},"content-version":"vor","delay-in-days":1516,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2001,12]]},"abstract":"<jats:p><jats:bold>A<jats:sc>bstract<\/jats:sc>: <\/jats:bold> An impressive body of evidence has suggested that estrogen therapy should be helpful to slow the pathogenesis or progression of atherosclerosis. Estrogen's favorable effects on lipids and endothelial function, coupled with extensive observational epidemiology and data from animal models of atherosclerosis, persuaded many that hormone replacement therapy (HRT) would be helpful for both primary and secondary prevention of coronary disease. Recently, several randomized clinical trials of HRT have been completed, and several more are currently under way. These trials include both primary and secondary prevention cohorts and use clinical as well as anatomic manifestations of atherosclerosis as outcomes. These trials are producing surprising and controversial results that will radically alter contemporary understanding of the role of HRT for cardiovascular disease prevention. This review briefly describes the findings of the Heart and Estrogen\/Progestin Replacement Study, the Estrogen Replacement and Atherosclerosis Trial, and other recently completed clinical trials. Trials that are under way are also described and discussed.<\/jats:p>","DOI":"10.1111\/j.1749-6632.2001.tb04014.x","type":"journal-article","created":{"date-parts":[[2010,7,20]],"date-time":"2010-07-20T21:25:26Z","timestamp":1279661126000},"page":"153-162","source":"Crossref","is-referenced-by-count":17,"title":["Cardiovascular Trials of Estrogen Replacement Therapy"],"prefix":"10.1111","volume":"949","author":[{"given":"DAVID M.","family":"HERRINGTON","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KAREN POTVIN","family":"KLEIN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,1,25]]},"reference":[{"key":"e_1_2_11_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.7.605"},{"key":"e_1_2_11_3_2","first-page":"795","article-title":"Hormone replacement therapy for secondary prevention of coronary heart disease [letter]","volume":"281","author":"Heckbert S.R.","year":"1999","journal-title":"J. Am. Med. Assoc."},{"key":"e_1_2_11_4_2","first-page":"I","article-title":"Postmenopausal hormones and recurrence of coronary events in the Nurses' Health Study [abstract]","volume":"100","author":"Grodstein F.","year":"1999","journal-title":"Circulation"},{"key":"e_1_2_11_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.284.1.41-a"},{"key":"e_1_2_11_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)07113-9"},{"key":"e_1_2_11_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)07114-0"},{"key":"e_1_2_11_8_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-132-9-200005020-00002"},{"key":"e_1_2_11_9_2","first-page":"1202","article-title":"Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case\u2010control study\u2014WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception","volume":"349","author":"WHO Collaborators","year":"1999","journal-title":"Lancet"},{"key":"e_1_2_11_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1998.tb10235.x"},{"key":"e_1_2_11_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.97.11.1037"},{"key":"e_1_2_11_12_2","first-page":"II\u2010278\u2010II","article-title":"The effect of exogenous estrogen on atherothrombotic vascular disease risk relates to the presence or absence of the 20210 G\/A prothrombin gene mutation: a cross\u2010sectional study of 230 hyperlipidemic women","volume":"102","author":"Glueck C.J.","year":"2000","journal-title":"Circulation"},{"key":"e_1_2_11_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.19.4.893"},{"key":"e_1_2_11_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.7.713"},{"key":"e_1_2_11_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.7.717"},{"key":"e_1_2_11_16_2","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1055\/s-0037-1614600","article-title":"Increased C\u2010reactive protein levels during short\u2010term hormone replacement therapy in healthy postmenopausal women","volume":"81","author":"Baal W.M.","year":"1999","journal-title":"Thromb. Haemostasis"},{"key":"e_1_2_11_17_2","doi-asserted-by":"publisher","DOI":"10.1353\/pbm.1993.0004"},{"key":"e_1_2_11_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199704033361401"},{"key":"e_1_2_11_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.17.6.1121"},{"key":"e_1_2_11_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.96.12.4204"},{"key":"e_1_2_11_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.98.9.839"},{"key":"e_1_2_11_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.99.2.237"},{"key":"e_1_2_11_23_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199408183310701"},{"key":"e_1_2_11_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.00273.x"},{"key":"e_1_2_11_25_2","doi-asserted-by":"publisher","DOI":"10.1177\/1358836X9800300309"},{"key":"e_1_2_11_26_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200008243430801"},{"key":"e_1_2_11_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.21.2.262"},{"key":"e_1_2_11_28_2","first-page":"212","article-title":"Transdermal hormone replacement therapy for secondary prevention of coronary artery disease in postmenopausal women [abstract]","volume":"21","author":"Clarke S.","year":"2000","journal-title":"Eur. Heart J."},{"key":"e_1_2_11_29_2","first-page":"II","article-title":"Estrogen in the prevention of atherosclerosis trial [abstract]","volume":"102","author":"Hodis H.N.","year":"2000","journal-title":"Circulation"},{"key":"e_1_2_11_30_2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1161\/str.32.suppl_1.329","article-title":"Effect of estrogen replacement on risk of recurrent stroke and death in the Women's Estrogen for Stroke Trial (WEST) [abstract]","volume":"32","author":"Viscoli C.M.","year":"2001","journal-title":"Stroke"},{"key":"e_1_2_11_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-2456(97)00078-0"}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1749-6632.2001.tb04014.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1749-6632.2001.tb04014.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T02:04:59Z","timestamp":1695607499000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1749-6632.2001.tb04014.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,12]]}},"alternative-id":["10.1111\/j.1749-6632.2001.tb04014.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1749-6632.2001.tb04014.x","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,12]]}}}